LFG
AMPH icon

Larson Financial Group’s Amphastar Pharmaceuticals AMPH Stock Holding History

Larson Financial Group’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$392 Sell
20
-748
-97% -$18.3K ﹤0.01% 3357
2025
Q4 		$20.6K Buy
768
+359
+88% +$9.25K ﹤0.01% 1707
2025
Q3 		$10.9K Buy
409
+381
+1,361% +$9.84K ﹤0.01% 1973
2025
Q2 		$643 Sell
28
-597
-96% -$14.8K ﹤0.01% 2786
2025
Q1 		$18.1K Buy
+625
New +$20K ﹤0.01% 1404

Other funds holding AMPH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return

Larson Financial Group's AMPH Position: Q1 2026 in Review

Larson Financial Group reduced its Amphastar Pharmaceuticals (AMPH) stake by 97% in Q1 2026, selling an estimated $18.3K and leaving 20 shares worth $392. The position accounts for ﹤0.01% of the portfolio, ranked #3357.

Larson Financial Group first reported a position in AMPH in Q1 2025 and has held it in 5 quarters since. The position peaked at $20.6K in Q4 2025. 215 funds tracked by Wall St. Rank hold AMPH as of Q1 2026.

  • Larson Financial Group held 20 shares of Amphastar Pharmaceuticals worth $392 as of Q1 2026.
  • Larson Financial Group sold 748 Amphastar Pharmaceuticals shares in Q1 2026, an estimated $18.3K.
  • Amphastar Pharmaceuticals made up ﹤0.01% of Larson Financial Group's portfolio in Q1 2026, its #3357 holding.
  • Larson Financial Group first reported a position in Amphastar Pharmaceuticals in Q1 2025 and has held it in 5 quarters since.
  • Larson Financial Group's Amphastar Pharmaceuticals position peaked at $20.6K in Q4 2025.
  • 215 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q1 2026.

Based on Larson Financial Group's 13F filing for Q1 2026, filed 15 May 2026.